Tibet AIM Pharm. Inc. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 403.325 million compared to CNY 347.181 million a year ago. Operating income was CNY 17.417 million compared to CNY 19.604 million a year ago. Net income was CNY 17.092 million compared to CNY 15.611 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.08 a year ago.